Zydus’s needle-free Covid vaccine may be introduced next week

Updated on Dec 17, 2021 04:31 AM IST

According to the company, the Centre has placed an order of 10 million vaccine doses, at ₹265 per dose

Beneficiaries receive Covid-19 vaccine shots at a vaccination centre in Thane on Thursday. The Centre announced that Zydus Cadila’s Covid-19 vaccine ZyCoV-D will initially be used in districts in seven states. (PTI)(HT_PRINT)
Beneficiaries receive Covid-19 vaccine shots at a vaccination centre in Thane on Thursday. The Centre announced that Zydus Cadila’s Covid-19 vaccine ZyCoV-D will initially be used in districts in seven states. (PTI)(HT_PRINT)
By, Hindustan Times, New Delhi

The Zydus Healthcare’s anti-coronavirus disease vaccine, ZyCoV-D, could be introduced in the national vaccination programme by next week, according to people familiar with the development.

“The training of vaccinators who would be administering the shots is nearly complete and the vaccine could be introduced very soon; likely by next week,” said a person aware of the matter on condition of anonymity.

ZyCoV-D, which is world’s first DNA-based and needle-free Covid-19 vaccine, has been approved for emergency use in people 12 years of age and above. However, in the absence of any policies in place on vaccinating children, the Union government has decided to first use the vaccine in adults.

According to the company, the Centre has placed an order of 10 million vaccine doses, at 265 per dose. Additionally, 93 will be charged as the cost of the needle-free intradermal applicator, which is required to administer the shot. The supplies are being released in a phased manner, according to people familiar with the matter.

ZyCoV-D, which is only the second indigenously developed Covid-19 vaccine besides Covaxin, will be initially used in districts of seven states that have low first dose coverage before being rolled out nationwide, one of the people cited above said. The seven states are Bihar, Jharkhand, Maharashtra, Punjab, Tamil Nadu, Uttar Pradesh and West Bengal.

The Central Drugs Laboratory in Kasauli, Himachal Pradesh, has cleared for market release close to 250,000 doses of the Zydus vaccine after putting the vials through stringent quality tests.

On August 20, the Drugs Controller General of India granted emergency use authorisation to ZyCoV-D but it is yet to be included in the vaccination drive.

Once rolled out, ZyCoV-D will become the third vaccine being used in the national vaccination programme, along with Covishield and Covaxin.

As on December 16, 87.5% of the eligible population has received at least one dose of the Covid-19 vaccine while 57.1% has been fully vaccinated.

Get Latest India Newsalong with Latest Newsand Top Headlinesfrom India and around the world.
SHARE THIS ARTICLE ON
  • ABOUT THE AUTHOR

    Rhythma Kaul works as an assistant editor at Hindustan Times. She covers health and related topics, including ministry of health and family welfare, government of India.

SHARE
Story Saved
×
Saved Articles
Following
My Reads
My Offers
Sign out
New Delhi 0C
Tuesday, December 06, 2022
Start 15 Days Free Trial Subscribe Now
Register Free and get Exciting Deals